跳至主要内容
临床试验/NCT07053098
NCT07053098招募中不适用

External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting

University of Maryland, Baltimore2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年3月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
2
主要终点
Prescribing medications for alcohol use disorder

研究概览

简要总结

This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics.

详细描述

This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics. Guided by the integrated Promoting Action on Research Implementation in Health Services framework, an external facilitator will work with each clinics' internal champion to (1) provide clinic level education on MAUD in non-specialty care settings, (2) provide clinic level training in using a standardized screen measure for alcohol use disorder, documenting screening results in the electronic health record, and documenting alcohol use disorder diagnosis in the electronic health record, (3) help internal champions use an audit and feedback system for weekly review of MAUD education and prescribing, (4) help internal champions do weekly care coordination for patients with major mental illness and alcohol use disorder, and (5) make educational materials on MAUD available on site to patients so they are informed about these treatment options. Internal champions and clinics will have access to consultation from a MAUD clinician expert. These activities will take place across pre-implementation and implementation phases and will be followed by a post-implementation facilitation sustainment period during which clinics and champions continue implementation on their own. Formative Evaluation activities will take place throughout; at the end of the sustainment phase, MAUD outcomes will be assessed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics.
  • •For patients: has major mental illness (major depressive disorders, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders; posttraumatic stress disorder)
  • •For patients: has Alcohol Use Disorder and is being treated in one of the three participating clinics.

排除标准

  • •For all: age is less than 18 years old
  • •For all: not able to complete informed consent

研究组 & 干预措施

Implementation Facilitation

Experimental

This Implementation Facilitation Intervention will include external facilitation, staff training, patient education, audit and feedback, and care coordination.

干预措施: Implementation Facilitation (Other)

结局指标

主要结局

Prescribing medications for alcohol use disorder

时间窗: 6 months after the end of implementation facilitation

Change in the proportion of eligible patients prescribed a medication for alcohol use disorder in the clinic

Prescribing medications for alcohol use disorder

时间窗: 6 months after the end of implementation facilitation

Change in the proportion of eligible patients prescribed a medication for alcohol use disorder in the clinic

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Melanie E Bennett

Professor

University of Maryland, Baltimore

研究点 (2)

Loading locations...

相似试验